Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. &amp; Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)

Marina Vladimirovna Shestakova; Irina Vladimirovna Glinkina

doi:10.14341/DM6022-3781

For citations:

Shestakova M.V., Glinkina I.V. Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506). Diabetes mellitus. 2010;13(1):88-90. (In Russ.) https://doi.org/10.14341/2072-0351-6022

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

For citations:

Cookies policy